ACCESO EXPANDIDO SUNITINIB: CARACTERÍSTICAS DE
LOS PACIENTES
All pts
Pt subgroups
Prior
cytokine
No
nephrec
Brain
mets
ECOG
PS>2
Non-clear
cell
Age >65
yrs
Evaluable pts
4,349
2,963
146
320
582*
588
1.414
PFS, mos
10.9
10.8
6.5
5.6
5.1
7.8
11.3
OS, mos
18.4
18.4
11
9.2
6.7
13.4
18.2
Gore ME, et al. Br J Cancer 2015;113:12‐9
